RBC Capital analyst Leonid Timashev lowered the price target on Insmed (NASDAQ: INSM) to $195.00 (from $205.00) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE